Beruflich Dokumente
Kultur Dokumente
Juan Ausió
Department of
Biochemistry and
Microbiology
University of Victoria
B
NTD MBD ID TRD CTDα CTDβ
mecp2 C
D
MeCP2
E1
4h
E2
100 h
Linker Nucleosome
Linker
Linker Nucleosome
Nucleosome
DNA core particle
DNA
DNA core
coreparticle
particle
Me CpG
Me
Me CpG
CpG
Rett syndrome is caused by mutations in MeCP2
Andreas Rett
MeCP2 chromatin binding domains and PTMs
Mutations throughout are important
a N
C
b
24 25 92 94 131 142 147 161 241 245 261 268 283 286 317-9 333 413 435
d 78 92 176 215
AT hook
276 285 308 384 385 467
MBD DNA binding Binary chromatin
domain binding sites
e
158 304 325 498
Dimerizing domain WDR
MeCP2 PTMs
MeCP2 mutation dependence severity of the Rett
syndrome phenotype
Kerr, Percy and Pineda scores for all mutations—C-terminal deletions are circled (adjusted for age
and data source).
.
Updating the profile of C-terminal MECP2 deletions in Rett syndrome.
Bebbington A, Percy A, Christodoulou J, Ravine D, Ho G, Jacoby P, Anderson A, Pineda M,
Ben Zeev B, Bahi-Buisson N, Smeets E, Leonard H.
J Med Genet. 2010 47:242-248.
MeCP2 distribution in HeLa cell chromatin
SI SE P SI SE P SI SE P
S1 SE P MeCP2
H3K9me2
H4
H3K27me3
1 2 3
H3K4me3
1 0.25 M sucrose
H3K36me3 10 mM Tris-HCl (pH 8.0)
0.5 mM CaCl2 3 50 mM KCl
pan-Ac H4
2 0.1 M KCl 10 mM Pipes (pH 6.8)
5.0 mM MgCl2
H4 10 mM Tris-HCl (pH 7.5)
1.0 mM CaCl2
1.0 mM CaCl2
Distribution of MeCP2in HeLa cells in response to treatment
with DNA methylating and de-methylating agents
MeCP2 is present in a 30-60 fold excess in brain over other
tissues and it is present in one of every three nucleosomes
MeCP2
Histone H3
B C
MeCP2 chromatin fractionation depends on the extent of nuclease digestion
Most of MeCP2 from brain chromatin is bound to non-
nucleosomal regions in brain
The high nuclease accessibility of the MeCP2-containing
protein question the early models and supports the
notion that MeCP2 is a REGULATOR of gene transcription
Brain chromatin has a 30-60 fold excess of MeCP2 compared to other tissues
and it contains approximately one molecule of MeCP2 for every three
nucleosomes
Rett
syndrome
Downsyndrome
ADHD/ADD
Cocaine
Alzheimer
Huntington
Depression
Parkinson
Epilepsy
MeCP2
MeCP2, beyond Rett syndrome
The remaining questions
Where is MeCP2 precisely bound in brain (neurons), and how does all this change during
development? Why is there so much?
What are the functional differences between the MeCP2 E1 and E2 isoforms?
What is the significance of the different amounts of the two MeCP2 isoforms in different
tissues?
What are the roles of PTMs already described, such as ubiquitination and acetylation in
particular, and the still to be uncovered MeCP2 PTMs?
Anita
Marlee Ng Thambirajah
Department of Oncology
Michael Hendzel
University of Alberta
Department of Biological Sciences
Philippe Georgel
Marshall University
Genome BC Proteomics Centre
Christoph Borchers
University of Victoria
The remaining questions
Where is MeCP2 precisely bound in brain (neurons), and how does all this change during
development? Why is there so much?
What are the functional differences between the MeCP2 E1 and E2 isoforms?
What is the significance of the different amounts of the two MeCP2 isoforms in different
tissues?
What are the roles of PTMs already described, such as ubiquitination and acetylation in
particular, and the still to be uncovered MeCP2 PTMs?
1.0
0.8
Recovery
0.6
0.4
0.2
0.0
MeCP2
Histone H1
0 20 40 60 80 100 120
Time (s)
(a)
mC
hm/mCpG.[A/T]≥4 H1
MeCP2
200 bp
MeCP2 MBD
AAATT (1)
(b)
Histone H1 WHD
N
(c)
165 bp
Repeat length bp
200
L
H1
A
(2)
A
MeCP2
180
165 bp N
160
(3) 0 7 14
days
Most of MeCP2 from liver chromatin is bound to
nucleosomal regions
0.6
0.2
0.0
0 5 10 15 20 25
Fraction number
H3
SI H
H2A
H2B
H4
W MeCP2
SE H1
H
H3
H2A
H2B
H4
W MeCP2